FindTrial
Sign In

Clinical observation on the effect and complications of transaxillary-subclavian infusion port implantation

Clinical observation on the effect and complications of transaxillary-subclavian infusion port implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058035
Enrollment
Unknown
Registered
2022-03-27
Start date
2022-03-26
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infusion port complications

Interventions

Experimental group:Port implantation of transaxillary subclavian intravenous infusion

Sponsors

Shulan (Hangzhou) Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The patients, aged 18-70 years and regardless of gender, voluntarily received right axilla-subclavian vein implantation in our hospital.

Exclusion criteria

Exclusion criteria: 1. After understanding the advantages and disadvantages of the operation, can not accept the solution; 2. Patients with abnormal coagulation function or damaged skin in the surgical area; 3. The depth of the venous center of the puncture target area is greater than 5cm from the skin.

Design outcomes

Primary

MeasureTime frame
catheter-attached thrombosis;pinch-off syndrome;—

Countries

China

Contacts

Public ContactLi Jun

Department of Anesthesiology, Shulan (Hangzhou) Hospital

great1010@126.com+86 13003696906

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026